Effect of norepinephrine and phenylephrine on prothrombotic response in patients undergoing cesarean section under spinal anesthesia: protocol for a randomized, double-blind, controlled study.
Trials
; 25(1): 432, 2024 Jul 02.
Article
in En
| MEDLINE
| ID: mdl-38956697
ABSTRACT
BACKGROUND:
Norepinephrine and phenylephrine are commonly used vasoactive drugs to treat hypotension during the perioperative period. The increased release of endogenous norepinephrine elicits prothrombotic changes, while parturients are generally in a hypercoagulable state. Therefore, this trial aims to investigate whether there is a disparity between equivalent doses of prophylactic norepinephrine infusion and phenylephrine infusion on prothrombotic response in patients undergoing cesarean section under spinal anesthesia.METHODS:
Sixty-six eligible parturients will be recruited for this trial and randomly assigned to the norepinephrine or phenylephrine group. The "study drug" will be administered at a rate of 15 ml/h starting from the intrathecal injection. The primary outcome are plasma coagulation factor VIII activity (FVIII C), fibrinogen, and D-dimer levels. The secondary outcomes include hemodynamic variables and umbilical artery blood pH value.DISCUSSION:
Our study is the first trial comparing the effect of norepinephrine and phenylephrine on prothrombotic response in patients undergoing cesarean section under spinal anesthesia. Positive or negative results will all help us better understand the impact of vasoactive drugs on patients. If there are any differences, this trial will provide new evidence for maternal choice of vasoactive medications in the perioperative period. TRIAL REGISTRATION Chinese Clinical Trial Registry ChiCTR2300077164. Registered on 1 November 2023. https//www.chictr.org.cn/ .Key words
Full text:
1
Database:
MEDLINE
Main subject:
Phenylephrine
/
Vasoconstrictor Agents
/
Norepinephrine
/
Randomized Controlled Trials as Topic
/
Cesarean Section
/
Anesthesia, Obstetrical
/
Anesthesia, Spinal
Limits:
Adult
/
Female
/
Humans
/
Pregnancy
Language:
En
Journal:
Trials
Journal subject:
MEDICINA
/
TERAPEUTICA
Year:
2024
Type:
Article
Affiliation country:
China